戻る
Argent BioPharma Limited (RGTLF)価格
RGTLF 株価推移チャート
RGTLF 収入
Argent BioPharma Limited
$0.06
0%
$0
終値： Jan 22, 16:00:00 GMT-5
$0.06
0%
$0
アフターマーケット：Jan 22, 20:00:00 GMT-5
Earnings FAQ
RGTLFの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Argent BioPharma Limited RGTLFの前四半期の収益はどうでしたか？
Argent BioPharma Limitedの収益見積もりはいくらですか？
Argent BioPharma Limitedの収益品質スコアはどれくらいですか？
Argent BioPharma Limitedはいつ収益を報告しますか？
Argent BioPharma Limitedの予想収益はいくらですか？
Argent BioPharma Limitedは収益予想を上回りましたか？
主要データ
前終値
$0.065
始値
$0.05
当日レンジ
$0.05 - $0.065
52週レンジ
$0.0105 - $0.2092
取引高
50.0K
平均取引高
3.0K
1株当たり利益(TTM)
-0.21
配当利回り
--
時価総額
$5.4M
Argent BioPharma Limitedとは何ですか？
Argent BioPharma Ltd. engages in the production of medical marijuana. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. The company focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The firm has a patient base in Australia, the United Kingdom, Brazil, and Ireland.